Analyst Expectations For Rhythm Pharmaceuticals's FutureBenzinga • 8 days ago
Latest Ratings for RYTM
DateFirmActionFromTo Mar 2022Canaccord GenuityMaintainsBuy Mar 2022NeedhamMaintainsBuy Feb 2022NeedhamMaintainsBuy
View More Analyst Ratings for RYTM
View the...
Share to Feed
Latest Ratings for RYTM
DateFirmActionFromTo Mar 2022Canaccord GenuityMaintainsBuy Mar 2022NeedhamMaintainsBuy Feb 2022NeedhamMaintainsBuy
View More Analyst Ratings for RYTM
View the...
For the last three days, A.I.dvisor has detected that RYTM's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Rhythm Pharmaceuticals gets $150M in convertible preferred stock financing...
-- Proceeds from financing and existing cash on-hand sufficient to fund planned operations into 2026 --BOSTON, April 01, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a...
With the business potentially at an important milestone, we thought we'd take a closer look at Rhythm Pharmaceuticals...
This price move could be a signal that RYTM may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...
For the last three days, A.I.dvisor has detected that RYTM's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...
This is a signal that RYTM's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...